Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-myeloablative Conditioning”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Testing effectiveness (Phase 2)Ended earlyNCT00113646
What this trial is testing

Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma+1 more
Massachusetts General Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00566696
What this trial is testing

Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies

Who this might be right for
Leukemia, Acute Lymphocytic (ALL)Leukemia, Myeloid, Acute(AML)Leukemia, Myeloid, Chronic(CML)+5 more
St. Jude Children's Research Hospital 73
Early research (Phase 1)Study completedNCT00006042
What this trial is testing

Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT01370213
What this trial is testing

NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 25
Not applicableStudy completedNCT00525876
What this trial is testing

Non-Myeloablative Allogeneic Stem Cell Transplantation

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)WithdrawnNCT00085449
What this trial is testing

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)UnknownNCT00149006
What this trial is testing

Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors

Who this might be right for
Tumors
Hadassah Medical Organization 100
Very early researchStudy completedNCT01174940
What this trial is testing

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

Who this might be right for
Stem Cell Leukemia of Unclear LineageGraft Versus Host Disease
University of Kansas Medical Center 22
Early research (Phase 1)Study completedNCT01041508
What this trial is testing

Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.

Who this might be right for
Leukemia Lymphoblastic, AcuteAcute Myeloid LeukemiaNeoplasm Recurrent
Therapeutic Advances in Childhood Leukemia Consortium 18
Early research (Phase 1)Ended earlyNCT00282425
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis

Who this might be right for
Scleroderma
Richard Burt, MD 8
Testing effectiveness (Phase 2)Study completedNCT01760655
What this trial is testing

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 62
Testing effectiveness (Phase 2)Study completedNCT00185614
What this trial is testing

Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma

Who this might be right for
Blood CancerMultiple Myeloma
Wen-Kai Weng 63
Large-scale testing (Phase 3)Ended earlyNCT01445821
What this trial is testing

Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial

Who this might be right for
Scleroderma, Systemic
Northwestern University 44
Testing effectiveness (Phase 2)UnknownNCT02098512
What this trial is testing

Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients

Who this might be right for
Hodgkin Lymphoma
New York Medical College 20
Testing effectiveness (Phase 2)Study completedNCT01005576
What this trial is testing

Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia

Who this might be right for
Severe Thalassemia
Washington University School of Medicine 21
Testing effectiveness (Phase 2)Study completedNCT00006968
What this trial is testing

Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Jonsson Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07598110
What this trial is testing

FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR OLDER AND/OR FRAIL PATIENTS WITH AML

Who this might be right for
Acute Myeloid Leukemia
Institut Paoli-Calmettes 77
Testing effectiveness (Phase 2)WithdrawnNCT03365661
What this trial is testing

QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML

Who this might be right for
High-Risk Acute Myeloid LeukemiaTreatment-Related Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia+1 more
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT01883323
What this trial is testing

Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma

Who this might be right for
Metastatic, Stage III or Stage IV, Melanoma
University Health Network, Toronto 12
Next Page